Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2026-01-07 @ 1:09 PM
Study NCT ID:
NCT05242133
Status:
COMPLETED
Last Update Posted:
2022-10-18
First Post:
2022-01-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Peginterferon Beta-1a (CinnaGen) in Participants With Relapsing Remitting Multiple Sclerosis
Sponsor:
Cinnagen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PEG.CIN.AZ.94.III
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None